Alvotech
Biosimilars Law Bulletin | Rothwell Figg | Biologics and Biosimilars Practice
Biosimilar of Forteo launched in Japan by Mochida
Teva Delivers First US Forteo Equivalent :: Generics Bulletin
Teva Announces Approval of a Generic Version of Forteo® (teriparatide injection), in the U.S. | Business Wire
Teva Announces Approval of a Generic Version of Forteo® (teriparatide injection), in the U.S. | TEVA Stock News
Teva Announces Approval of a Generic Version of Forteo® (teriparatide injection), in the U.S. -November 17, 2023 at 08:31 am EST | MarketScreener
Teva Pharmaceutical Industries Ltd.
Pfenex: The First U.S. Forteo Biosim And A Host Of Other Biosims In Pipeline (NYSEMKT:PFNX) | Seeking Alpha
How the U.S. Compares to Europe on Biosimilar Approvals and Products In the Pipeline | Biosimilars Law Bulletin
Teva announces approval of a generic version of Forteo in US
Teva announces approval of a generic version of Forteo in US
Lilly faces biosimilar rivals to osteoporosis drug Forsteo in Europe | pharmaphorum
How the U.S. Compares to Europe on Biosimilar Approvals and Products In the Pipeline Updated March 14, 2022 | Rothwell, Figg, Ernst & Manbeck, P.C. - JDSupra
Teva Pharma is the way to play the re-rise of generic drugs
How the U.S. Compares to Europe on Biosimilar Approvals and Products In the Pipeline Updated March 14, 2022 | Biosimilars Law Bulletin
Strides Says Forsteo Biosimilar 'Significant Product', Seeks New Minority Investor In Stelis :: Scrip
Teva Raises Guidance Amid Generics Growth :: Generics Bulletin
EX-99.1
Teva Announces Approval of a Generic Version of Forteo® (teriparatide injection), in the U.S.
Osteoporosis Injection Treatment | FORTEO® (teriparatide injection)
Apotex And Ambio Shatter Hopes Of Teriparatide Exclusivity For Teva :: Generics Bulletin
FDA approves generic teriparatide and levetiracetam
Stada Arz in-licenses teriparatide, expanding its biosimilars portfoli
